INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $216,705 | -97.9% | 5,314 | -98.1% | 0.00% | -97.6% |
Q1 2023 | $10,219,583 | +221.4% | 274,204 | +200.9% | 0.04% | +223.1% |
Q4 2022 | $3,179,316 | +803.2% | 91,124 | +1348.7% | 0.01% | +550.0% |
Q3 2022 | $352,000 | -91.4% | 6,290 | -88.8% | 0.00% | -88.2% |
Q1 2022 | $4,074,000 | -69.0% | 56,057 | -42.7% | 0.02% | -55.3% |
Q3 2021 | $13,129,000 | +962.2% | 97,871 | +1182.5% | 0.04% | +660.0% |
Q2 2021 | $1,236,000 | -49.4% | 7,631 | -83.0% | 0.01% | -72.2% |
Q4 2020 | $2,443,000 | +67.8% | 44,899 | -38.7% | 0.02% | -10.0% |
Q3 2020 | $1,456,000 | +28.6% | 73,222 | +35.9% | 0.02% | +11.1% |
Q2 2020 | $1,132,000 | -2.7% | 53,872 | -21.0% | 0.02% | +50.0% |
Q1 2019 | $1,164,000 | +12.9% | 68,150 | -9.7% | 0.01% | 0.0% |
Q4 2018 | $1,031,000 | +10.9% | 75,499 | +132.3% | 0.01% | +9.1% |
Q3 2018 | $930,000 | +26.7% | 32,500 | +21.1% | 0.01% | +10.0% |
Q2 2018 | $734,000 | -19.8% | 26,829 | -38.2% | 0.01% | -33.3% |
Q1 2018 | $915,000 | +46.6% | 43,400 | +33.6% | 0.02% | +36.4% |
Q4 2017 | $624,000 | – | 32,483 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |